Jeff Odell, PharmD, R.Ph.

Jeff Odell, PharmD, R.Ph. is an experienced healthcare professional with a diverse background in market access and pharmaceutical management. Jeff currently serves as the Executive Director of Market Access at Provention Bio. Prior to this, they worked as the Director of National Accounts Market Access & Government Affairs at Ultragenyx Pharmaceutical Inc, leading the development and analysis of market access strategies for rare and ultra-rare disease products. Jeff also served as the Director of Strategic Accounts at ZS Pharma, where they were responsible for establishing and maintaining access for hyperkalemia products with national payers. Jeff has also held roles at Avanir Pharmaceuticals, Humana, Novartis Oncology, Amgen, Schering-Plough Pharmaceuticals, and Scott & White Healthcare, where they gained experience in formulary access strategies, contracting, and account management. Jeff holds a Doctor of Pharmacy degree and is a Registered Pharmacist.

Jeff Odell, PharmD, R.Ph. holds a Doctor of Pharmacy Degree (PharmD) from the University of Oklahoma Health Sciences Center, where they also obtained a Bachelor of Science Degree (BS) in Pharmacy. Jeff is a licensed pharmacist by the Texas State Board of Pharmacy. No specific details regarding the start or end years of their education or the month and year of their certification are provided.